A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This essential malignant protector protein is frequently inactivated in several kinds of cancer, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research